Evidence map›Paper›PMID 33003412›Full record

ArticleNutrients2020

Metabolic Defects Caused by High-Fat Diet Modify Disease Risk through Inflammatory and Amyloidogenic Pathways in a Mouse Model of Alzheimer's Disease.

Austin M Reilly, Andy P Tsai, Peter B Lin, Aaron C Ericsson, Adrian L Oblak, Hongxia Ren

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Austin M ReillyStark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Andy P TsaiStark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0001-6400-544X
Peter B LinStark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0002-8954-9045
Aaron C EricssonMetagenomics Center, University of Missouri, Columbia, MO 65201, USA.
Adrian L OblakStark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Hongxia RenStark Neurosciences Research Institute, Medical Neuroscience Graduate Program, Indiana University School of Medicine, Indianapolis, IN 46202, USA.ORCID 0000-0003-2909-4365
Indiana University School of MedicineUniversity of Missouri · US

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
Translation CoreP30DK097512 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI JEFFREY S ELMENDORF · 2015 to 2026
$17.4M
RESEARCH TRAINING PROGRAM IN DIABETES AND OBESITYT32DK064466 · NIDDK · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI Carmella Evans-Molina, RONALD C WEK · 2003 to 2026
$5.2M
Metabolic Function of Gpr17 in Gastrointestinal TractR01DK120772 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI REN, HONGXIA · 2020 to 2024
$2.0M
Gpr17 function in metabolism and satiety controlR00DK098294 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI REN, HONGXIA · 2016 to 2018
$730k
Impact of gut microbiota and segmented filamentous bacteria on colitis-associated colorectal cancerK01OD019924 · OD · UNIVERSITY OF MISSOURI-COLUMBIA · PI ERICSSON, AARON · 2016 to 2020
$573k
NCATS NIH HHS UL1TR002529NIDDK NIH HHS P30 DK097512NIDDK NIH HHS P30DK097512NIDDK NIH HHS R00 DK098294NIDDK NIH HHS R00DK098294NIDDK NIH HHS R01 DK120772NIDDK NIH HHS R01DK120772NIDDK NIH HHS T32 DK064466NIDDK NIH HHS T32DK064466NIH HHS K01 OD019924
6 · The paper itself

Abstract

High-fat diet (HFD) has been shown to accelerate Alzheimer's disease (AD) pathology, but the exact molecular and cellular mechanisms remain incompletely understood. Moreover, it is unknown whether AD mice are more susceptible to HFD-induced metabolic dysfunctions. To address these questions, we used 5xFAD mice as an Alzheimer's disease model to study the physiological and molecular underpinning between HFD-induced metabolic defects and AD pathology. We systematically profiled the metabolic parameters, the gut microbiome composition, and hippocampal gene expression in 5xFAD and wild type (WT) mice fed normal chow diet and HFD. HFD feeding impaired energy metabolism in male 5xFAD mice, leading to increased locomotor activity, energy expenditure, and food intake. 5xFAD mice on HFD had elevated circulating lipids and worsened glucose intolerance. HFD caused profound changes in gut microbiome compositions, though no difference between genotype was detected. We measured hippocampal mRNAs related to AD neuropathology and neuroinflammation and showed that HFD elevated the expression of apoptotic, microglial, and amyloidogenic genes in 5xFAD mice. Pathway analysis revealed that differentially regulated genes were involved in insulin signaling, cytokine signaling, cellular stress, and neurotransmission. Collectively, our results showed that 5xFAD mice were more susceptible to HFD-induced metabolic dysregulation and suggest that targeting metabolic dysfunctions can ameliorate AD symptoms via effects on insulin signaling and neuroinflammation in the hippocampus.

Indexed as

Alzheimer DiseaseAmyloidogenic ProteinsAnimalsApoptosis Regulatory ProteinsCytokinesDiet, High-FatDisease Models, AnimalEatingEnergy MetabolismGastrointestinal MicrobiomeGene ExpressionGenotypeGlucose IntoleranceHippocampusInflammationInsulinAmyloidogenic ProteinsApoptosis Regulatory ProteinsCytokinesInsulinLipidsRNA, MessengerAlzheimer’s diseasedietglucoseinsulinlipidmetabolismneuroinflammationnutrient

Identifiers

PMID33003412
PMCPMC7600118
OpenAlexW3090628550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.